AAAAAA

   
Results: 1-19 |
Results: 19

Authors: Alam, MR Donabedian, S Brown, W Gordon, J Chow, JW Zervos, MJ Hershberger, E
Citation: Mr. Alam et al., Heteroresistance to vancomycin in Enterococcus faecium, J CLIN MICR, 39(9), 2001, pp. 3379-3381

Authors: Vergis, EN Hayden, MK Chow, JW Snydman, DR Zervos, MJ Linden, PK Wagener, MM Schmitt, B Muder, RR
Citation: En. Vergis et al., Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia - A prospective multicenter study, ANN INT MED, 135(7), 2001, pp. 484-492

Authors: Brooks, A Ekleberry, A McMahon, J Begle, R Johnson, M Rizzo, J Zervos, MJ
Citation: A. Brooks et al., Evaluation of clinical practice guidelines on outcome of infection in medical intensive care unit patients, INF DIS C P, 9(8), 2000, pp. 339-348

Authors: Kak, V You, I Zervos, MJ Kariyama, R Kumon, H Chow, JW
Citation: V. Kak et al., In-vitro synergistic activity of the combination of ampicillin and arbekacin against vancomycin-and high-level gentamicin-resistant Enterococcus faecium with the aph(2 '')-Id gene, DIAG MICR I, 37(4), 2000, pp. 297-299

Authors: You, I Kariyama, R Zervos, MJ Kumon, H Chow, JW
Citation: I. You et al., In-vitro activity of arbekacin alone and in combination with vancomycin against gentamicin- and methicillin-resistant Staphylococcus aureus, DIAG MICR I, 36(1), 2000, pp. 37-41

Authors: Donabedian, S Hershberger, E Thal, LA Chow, JW Clewell, DB Robinson-Dunn, B Zervos, MJ
Citation: S. Donabedian et al., PCR fragment length polymorphism analysis of vancomycin-resistant Enterococcus faecium, J CLIN MICR, 38(8), 2000, pp. 2885-2888

Authors: Snyder, JW Benzing, KS Munier, GK Bostic, GD Bozigar, PS Hanna, R Zervos, MJ
Citation: Jw. Snyder et al., Clinical comparison of nonvented aerobic BacT/Alert blood culture bottle and standard aerobic bottle for detection of microorganisms in blood, J CLIN MICR, 38(10), 2000, pp. 3864-3866

Authors: Kak, V Donabedian, SM Zervos, MJ Kariyama, R Kumon, H Chow, JW
Citation: V. Kak et al., Efficacy of ampicillin plus arbekacin in experimental rabbit endocarditis caused by an Enterococcus faecalis strain with high-level gentamicin resistance, ANTIM AG CH, 44(9), 2000, pp. 2545-2546

Authors: Hershberger, E Coyle, EA Kaatz, GW Zervos, MJ Rybak, MJ
Citation: E. Hershberger et al., Comparison of a rabbit model of bacterial endocarditis and an in vitro infection model with simulated endocardial vegetations, ANTIM AG CH, 44(7), 2000, pp. 1921-1924

Authors: Kao, SJ You, L Clewell, DB Donabedian, SM Zervos, MJ Petrin, J Shaw, KJ Chow, JW
Citation: Sj. Kao et al., Detection of the high-level aminoglycoside resistance gene aph(2 '')-Ib inEnterococcus faecium, ANTIM AG CH, 44(10), 2000, pp. 2876-2879

Authors: Brooks, A Ekleberry, A McMahon, J Begle, R Johnson, M Rizzo, J Zervos, MJ
Citation: A. Brooks et al., Evaluation of clinical practice guidelines on outcome of infection in medical intensive care unit patients, INF DIS C P, 8(2), 1999, pp. 97-106

Authors: Silverman, J Vazquez, JA Sobel, JD Zervos, MJ
Citation: J. Silverman et al., Comparative in vitro activity of antiseptics and disinfectants versus clinical isolates of Candida species, INFECT CONT, 20(10), 1999, pp. 676-684

Authors: Thal, LA Zervos, MJ
Citation: La. Thal et Mj. Zervos, Occurrence and epidemiology of resistance to virginiamycin and streptogramins, J ANTIMICRO, 43(2), 1999, pp. 171-176

Authors: Price, J Ekleberry, A Grover, A Melendy, S Baddam, K McMahon, J Villalba, M Johnson, M Zervos, MJ
Citation: J. Price et al., Evaluation of clinical practice guidelines on outcome of infection in patients in the surgical intensive care unit, CRIT CARE M, 27(10), 1999, pp. 2118-2124

Authors: Zervos, MJ
Citation: Mj. Zervos, Cefepime versus ceftriaxone for empiric treatment of hospitalized patientswith community-acquired pneumonia - Reply, ANTIM AG CH, 43(2), 1999, pp. 436-437

Authors: Smith, TL Pearson, ML Wilcox, KR Cruz, C Lancaster, MV Robinson-Dunn, B Tenover, FC Zervos, MJ Band, JD White, E Jarvis, WR
Citation: Tl. Smith et al., Emergence of vancomycin resistance in Staphylococcus aureus, N ENG J MED, 340(7), 1999, pp. 493-501

Authors: Brooks, AK Zervos, MJ
Citation: Ak. Brooks et Mj. Zervos, New antimicrobial agents for Gram-positive infections, CURR OPIN I, 11(6), 1998, pp. 667-671

Authors: Chow, JW Donabedian, SM Clewell, DB Sahm, DF Zervos, MJ
Citation: Jw. Chow et al., In vitro susceptibility and molecular analysis of gentamicin-resistant enterococci, DIAG MICR I, 32(3), 1998, pp. 141-146

Authors: Kariyama, R Kumon, H Chow, L Zervos, MJ Takata, T Tabata, M Chow, JW
Citation: R. Kariyama et al., In-vitro activity of the combination of ampicillin and arbekacin against high-level gentamicin-resistant enterococci, J ANTIMICRO, 42(6), 1998, pp. 836-838
Risultati: 1-19 |